4//SEC Filing
Davis Andrew S. 4
Accession 0001140361-24-041410
CIK 0001397702other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 8:27 PM ET
Size
19.1 KB
Accession
0001140361-24-041410
Insider Transaction Report
Form 4
Davis Andrew S.
EVP Global Sales & Marketing
Transactions
- Award
Common Stock
2024-09-17+42,218→ 42,218 total - Disposition to Issuer
Common Stock
2024-09-17−290,077→ 0 total - Disposition to Issuer
Common Stock
2024-09-17−42,218→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2024-09-17$22.77/sh−62,958$1,433,554→ 0 totalExercise: $4.73Exp: 2027-11-30→ Common Stock (62,958 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2024-09-17$7.50/sh−33,220$249,150→ 0 totalExercise: $20.00Exp: 2029-04-03→ Common Stock (33,220 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2024-09-17$25.90/sh−22,033$570,655→ 0 totalExercise: $1.60Exp: 2025-12-03→ Common Stock (22,033 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2024-09-17$21.39/sh−1,853$39,636→ 0 totalExercise: $6.11Exp: 2028-09-13→ Common Stock (1,853 underlying)
Footnotes (10)
- [F1]Of the reported shares, 219,965 are represented by restricted stock units, or RSUs, each of which represents a contingent right to receive one share of Issuer common stock.
- [F10]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $249,150.00, which represents the difference between (i) the amount by which the Merger Consideration exceeded the exercise price of the option per share option and (ii) the aggregate number of shares remaining issuable upon exercise of the option, less applicable taxes and authorized deductions.
- [F2]Includes 370 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan on September 13, 2024.
- [F3]Pursuant to the Agreement and Plan of Merger dated June 17, 2024, between the Issuer, Boston Scientific Corporation and Seminole Merger Sub, Inc, (the "Merger Agreement"), each share of Issuer common stock was canceled and converted into the right to receive $27.50 per share in cash (the "Merger Consideration"), without interest and subject to applicable withholding taxes.
- [F4]Pursuant to the Merger Agreement, each RSU was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the Merger Consideration and (ii) the aggregate number of shares underlying the RSUs, less applicable taxes and authorized deductions.
- [F5]Immediately prior to the effective time of the merger, certain RSUs subject to the achievement of performance-based criteria, or PSUs, were deemed achieved and certified by the Issuer's compensation committee.
- [F6]Pursuant to the Merger Agreement, each PSU was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the Merger Consideration and (ii) the aggregate number of shares underlying the PSUs, less applicable taxes and authorized deductions.
- [F7]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $570,654.70, which represents the difference between (i) the amount by which the Merger Consideration exceeded the exercise price of the option per share option and (ii) the aggregate number of shares remaining issuable upon exercise of the option, less applicable taxes and authorized deductions.
- [F8]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $1,433,553.66, which represents the difference between (i) the amount by which the Merger Consideration exceeded the exercise price of the option per share option and (ii) the aggregate number of shares remaining issuable upon exercise of the option, less applicable taxes and authorized deductions.
- [F9]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $39,635.67, which represents the difference between (i) the amount by which the Merger Consideration exceeded the exercise price of the option per share option and (ii) the aggregate number of shares remaining issuable upon exercise of the option, less applicable taxes and authorized deductions.
Documents
Issuer
Silk Road Medical Inc
CIK 0001397702
Entity typeother
Related Parties
1- filerCIK 0001770191
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 8:27 PM ET
- Size
- 19.1 KB